Parallel Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$63 | – | 3598 |
|
|
2025
Q1 | $63 | Buy |
+3
| New | +$63 | ﹤0.01% | 3446 |
|
|
2022
Q2 | – | Sell |
-332
| Closed | -$12K | – | 3139 |
|
|
2022
Q1 | $12K | Sell |
332
-836
| -72% | -$30.2K | ﹤0.01% | 1914 |
|
|
2021
Q4 | $51K | Buy |
1,168
+836
| +252% | +$36.5K | ﹤0.01% | 1298 |
|
|
2021
Q3 | $17K | Buy |
332
+98
| +42% | +$5.02K | ﹤0.01% | 1803 |
|
|
2021
Q2 | $12K | Sell |
234
-523
| -69% | -$26.8K | ﹤0.01% | 1908 |
|
|
2021
Q1 | $35K | Hold |
757
| – | – | ﹤0.01% | 1320 |
|
|
2020
Q4 | $35K | Sell |
757
-93
| -11% | -$4.3K | ﹤0.01% | 1225 |
|
|
2020
Q3 | $33K | Buy |
850
+93
| +12% | +$3.61K | ﹤0.01% | 1224 |
|
|
2020
Q2 | $28K | Buy |
+757
| New | +$28K | ﹤0.01% | 1276 |
|